Long-term Responders to Nanoparticle Albumin-bound Paclitaxel Following Immune Checkpoint Inhibitor in Non-small Cell Lung Cancer
Anticancer Research · 2024
DOI: 10.21873/anticanres.17335 ↗Kurz gefasst
Fachartikel in der Zeitschrift Anticancer Research, 2024. Verfasst von Koki Nakashima und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Medicine, Faculty of Medical Sciences, University of Fukui, Fukui, Japan; kouk0527@yahoo.co.jp. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Immune Checkpoint Inhibitors, Lung Neoplasms, Albumin-Bound Paclitaxel.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Respiratory Medicine, Faculty of Medical Sciences, University of Fukui, Fukui, Japan; kouk0527@yahoo.co.jp.
- Department of Respiratory Medicine, Faculty of Medical Sciences, University of Fukui, Fukui, Japan.
- Department of Respiratory Medicine, Japanese Red Cross Fukui Hospital, Fukui, Japan.
Zitieren
APA
Nakashima, K., Umeda, Y., Demura, Y., Yamaoka, K., Sonoda, T., Tada, T., Waseda, Y., & Ishizuka, T. (2024). Long-term Responders to Nanoparticle Albumin-bound Paclitaxel Following Immune Checkpoint Inhibitor in Non-small Cell Lung Cancer. Anticancer Research. https://doi.org/10.21873/anticanres.17335
Vancouver
Nakashima K, Umeda Y, Demura Y, Yamaoka K, Sonoda T, Tada T, et al. Long-term Responders to Nanoparticle Albumin-bound Paclitaxel Following Immune Checkpoint Inhibitor in Non-small Cell Lung Cancer. Anticancer Research. 2024. doi:10.21873/anticanres.17335
BibTeX
@article{Nakashima2024,
author = {Nakashima, Koki and Umeda, Yukihiro and Demura, Yoshiki and Yamaoka, Koji and Sonoda, Tomoaki and Tada, Toshihiko and Waseda, Yuko and Ishizuka, Tamotsu},
title = {Long-term Responders to Nanoparticle Albumin-bound Paclitaxel Following Immune Checkpoint Inhibitor in Non-small Cell Lung Cancer},
journal = {Anticancer Research},
year = {2024},
doi = {10.21873/anticanres.17335}
}
EUVIMED